Physician profile
Robert M Norris
NPI 1528061462
$640.70
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $345 · 2020: $119 · 2021: $152 · 2022: $24.42.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $332.49 | 2019-2021 | |
| Bard Peripheral Vascular, INC. | $102.76 | 2019 | |
| Intuitive Surgical, INC. | $62.36 | 2019-2022 | |
| Biocomposites INC | $43.36 | 2020 | |
| Focal Therapeutics, INC. | $41.50 | 2019-2020 | |
| Innocoll Pharmaceuticals Limited | $31.35 | 2021 | |
| Nalpropion Pharmaceuticals LLC | $15.41 | 2019 | |
| Merck Sharp & Dohme LLC | $11.47 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Norris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.